ImmunoCellular Therapeutics (IMUC.OB) Safety and Efficacy Results for Glioblastoma Trial
April 15th, 2011
No comments
IMUC.OB presented safety and preliminary efficacy data of the PI dendritic cell cancer clinical trial Read more…
